SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor

SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has demonstrated the value of pursuing different vaccine strategies. Vaccines based on whole viruses, a widely used vaccine technology, depend on efficient virus production. This study aimed to establish SARS-CoV-2 production...

Full description

Bibliographic Details
Main Authors: Anna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, Rui Costa, Nandini Prabhakar Venkatesan, Xiangliang Lin, Long Van Pham, Shan Feng, Ulrik Fahnøe, Troels Kasper Høyer Scheel, Santseharay Ramirez, Udo Reichl, Jens Bukh, Yvonne Genzel, Judith Margarete Gottwein
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Vaccines
Subjects:
severe acute respiratory syndrome coronavirus 2
COVID-19
scalable bioreactor
CelCradle
packed-bed
whole virus vaccine
Online Access:https://www.mdpi.com/2076-393X/9/7/706

Internet

https://www.mdpi.com/2076-393X/9/7/706

Similar Items